fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

H1 2013 financial results

Download

CARMAT publishes its fourth Shareholder Newsletter

Download

CARMAT subscribes to a contingent equity line

Download

Q&A on the contingent equity line

Download

The responses to written questions to CARMAT’s Board of Directors are now available

Download

Agreement with the Prince Sultan Cardiac Center in Riyadh to perform implants of CARMAT’s heart

Download

Agreement with St Pierre University Hospital, in Brussels to perform implantations of CARMAT’s heart

Download

Agreement with the Silesian Center for Heart Diseases in Zabrze, Poland, to perform implants of CARMAT’s heart

Download
Top of page